FSD Pharma (FSDDF) Stock Price, News & Analysis

Company Overview

FSD Pharma Inc. is a clinical-stage biopharmaceutical company focused on the development of molecular cannabinoid-derived therapies. Headquartered in Ontario, Canada, the company leverages advanced drug formulation techniques to create targeted treatments for pain management, inflammatory conditions, and neurodegenerative disorders. Since its founding, FSD Pharma has transitioned from a pure-play cannabis operator to a research-driven pharmaceutical developer, emphasizing rigorous preclinical studies and clinical trial design.

The company’s product pipeline includes novel cannabinoid formulations engineered for optimized bioavailability and therapeutic consistency. Lead candidates in development target chronic and neuropathic pain, as well as central nervous system disorders. FSD Pharma’s research strategy encompasses both in-house discovery efforts and strategic collaborations with academic institutions, enabling access to specialized drug delivery platforms and proprietary cannabinoid analogs.

In support of its development activities, FSD Pharma operates GMP-compliant manufacturing facilities in Canada for the cultivation, extraction, and formulation of cannabinoid compounds. These facilities are designed to meet stringent quality standards and provide scalability for both clinical trial material and future commercial supply. The company’s commercial footprint extends across North America, with ongoing efforts to secure regulatory approvals and partnerships in key markets.

FSD Pharma is led by a management team with extensive experience in pharmaceutical development, clinical research, and regulatory affairs. The board of directors includes industry veterans who have overseen multiple drug submissions to health authorities in North America and Europe. With a strategic focus on advancing its pipeline through clinical milestones, FSD Pharma aims to address unmet medical needs by harnessing the therapeutic potential of cannabinoids in a pharmaceutical context.

Key Stats

• Today's Range: $16.49 to $19.19
• 50-Day Range: $6.51 to $35.00
• 52-Week Range: $3.43 to $68.66
• Volume: 330,019 shs
• Average Volume: 11,100 shs
• Market Capitalization: $129.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FSDDF Stock Analysis - Frequently Asked Questions

How have FSDDF shares performed this year?

FSD Pharma's stock was trading at $3.68 at the start of the year. Since then, FSDDF shares have increased by 363.6% and is now trading at $17.06.

How do I buy shares of FSD Pharma?

Shares of FSDDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Agricultural Commodities & Milling
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:FSDDF
• Previous Symbol: OTCMKTS:FSDDF
• CIK: N/A
• Web: N/A
• Phone: (416) 854-8884
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.81
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $70 thousand
• Price / Sales: 1,847.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,580,000
• Free Float: N/A
• Market Cap: $129.31 million
• Optionable: Not Optionable
• Beta: N/A